Summary

The global volumetric infusion pumps market is experiencing consistent growth as healthcare systems increasingly rely on precise drug delivery technologies. Volumetric infusion pumps are essential medical devices designed to administer fluids, medications, and nutrients in controlled quantities over specific time intervals. Their importance in ensuring patient safety and treatment accuracy has made them a cornerstone of modern clinical practice. The market is projected to reach USD 1.5 billion in 2026 and is anticipated to grow to USD 2.2 billion by 2033, registering a compound annual growth rate (CAGR) of 6.00% during the forecast period.

Market Insights

The adoption of volumetric infusion pumps is expanding across various healthcare settings, including hospitals, ambulatory surgical centers, and home care environments. These devices are widely used in intensive care units, emergency departments, and operating rooms due to their precision and reliability. Technological advancements have significantly enhanced the functionality of infusion pumps, with features such as programmable settings, wireless connectivity, and integration with hospital information systems becoming increasingly common.

In addition, the shift toward digital healthcare solutions has encouraged the development of smart infusion pumps capable of minimizing medication errors and improving workflow efficiency. The demand for portable and compact infusion devices is also rising, particularly among patients receiving long-term therapies at home.

Market Drivers

The rising prevalence of chronic diseases is a major factor driving the growth of the volumetric infusion pumps market. Conditions such as cancer, diabetes, and cardiovascular disorders often require continuous or repeated administration of medications, increasing the need for reliable infusion systems. The growing geriatric population further contributes to this demand, as older individuals are more likely to require ongoing medical care.

Another important driver is the increasing number of surgical procedures worldwide. Infusion pumps are critical in surgical settings for delivering anesthesia, fluids, and post-operative medications. As healthcare facilities expand and surgical volumes rise, the demand for these devices continues to grow.

Patient safety concerns are also playing a significant role in market expansion. Healthcare providers are increasingly adopting advanced infusion systems equipped with safety mechanisms such as dose error reduction software and real-time monitoring capabilities to minimize risks associated with medication administration.

Business Opportunity

The market presents significant opportunities for growth, particularly in the area of home healthcare. As more patients opt for treatment in the comfort of their homes, the demand for portable and user-friendly infusion pumps is increasing. Manufacturers are focusing on developing devices that are easy to operate, lightweight, and suitable for non-clinical settings.

Emerging economies offer substantial potential due to ongoing improvements in healthcare infrastructure and rising healthcare expenditure. Increased awareness of advanced treatment options and greater access to medical technologies are expected to drive market growth in these regions.

Innovation remains a key area of opportunity, with companies investing in research and development to create next-generation infusion systems. The integration of data analytics, remote monitoring, and connectivity features is expected to enhance patient outcomes and streamline healthcare operations.

Region Analysis

North America continues to lead the volumetric infusion pumps market, supported by a well-established healthcare system, high adoption of advanced technologies, and strong emphasis on patient safety. The presence of major market players further strengthens the region’s position.

Europe represents another significant market, driven by an aging population, increasing incidence of chronic diseases, and supportive healthcare policies. The region is witnessing steady adoption of advanced infusion technologies across healthcare facilities.

Asia Pacific is expected to register the fastest growth during the forecast period. Rapid economic development, expanding healthcare infrastructure, and increasing demand for quality medical care are key factors contributing to this growth. Countries such as China and India are emerging as important markets due to their large patient populations and improving access to healthcare services.

Latin America and the Middle East and Africa are also experiencing gradual growth, supported by rising healthcare investments and growing awareness about modern medical devices.

Key Players

The market is characterized by intense competition, with leading companies focusing on innovation, strategic partnerships, and product development to maintain their competitive edge. Key players in the market include:

• 3M

• Braun Melsungen AG

• Baxter

• Becton Dickinson and Company

• Fresenius Kabi AG

• ICU Medical Inc

• Smiths Medical

• Terumo Medical Corporation

• Avanos Medical, Inc.

• Medtronic plc

• Hospira (a subsidiary of Pfizer Inc.)

• Roche Diagnostics

These companies are actively working to introduce advanced infusion systems with enhanced safety features and improved performance.

Conclusion

The volumetric infusion pumps market is set to witness steady expansion over the coming years, driven by increasing demand for accurate drug delivery systems and continuous advancements in medical technology. The growing focus on patient safety, coupled with the rising adoption of home healthcare solutions, is expected to further boost market growth. As emerging regions continue to invest in healthcare infrastructure and key players drive innovation, the market is poised for sustained development.

Market Segmentation

By Product Outlook

• Volumetric Infusion Pumps

• Insulin Infusion Pumps

• Syringe Infusion Pumps

• Enteral Infusion Pumps

• Ambulatory Infusion Pumps

• Patient Controlled Analgesia (PCA)

• Implantable Infusion Pumps

• Others

By Disease Indication

• Chemotherapy

• Diabetes

• Gastroenterology

• Analgesia/Pain Management

• Pediatrics/Neonatology

• Hematology

• Others

By Region

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Volumetric Infusion Pumps Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Volumetric Infusion Pumps Market Outlook, 2020-2033
3.1. Global Volumetric Infusion Pumps Market Outlook, by Product Outlook, Value (US$ Bn), 2020-2033
3.1.1. Volumetric Infusion Pumps
3.1.2. Insulin Infusion Pumps
3.1.3. Syringe Infusion Pumps
3.1.4. Enteral Infusion Pumps
3.1.5. Ambulatory Infusion Pumps
3.1.6. Patient Controlled Analgesia (PCA)
3.1.7. Implantable Infusion Pumps
3.1.8. Others
3.2. Global Volumetric Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
3.2.1. Chemotherapy
3.2.2. Diabetes
3.2.3. Gastroenterology
3.2.4. Analgesia/Pain Management
3.2.5. Pediatrics/Neonatology
3.2.6. Hematology
3.2.7. Others
3.3. Global Volumetric Infusion Pumps Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.3.1. North America
3.3.2. Europe
3.3.3. Asia Pacific
3.3.4. Latin America
3.3.5. Middle East & Africa
4. North America Volumetric Infusion Pumps Market Outlook, 2020-2033
4.1. North America Volumetric Infusion Pumps Market Outlook, by Product Outlook, Value (US$ Bn), 2020-2033
4.1.1. Volumetric Infusion Pumps
4.1.2. Insulin Infusion Pumps
4.1.3. Syringe Infusion Pumps
4.1.4. Enteral Infusion Pumps
4.1.5. Ambulatory Infusion Pumps
4.1.6. Patient Controlled Analgesia (PCA)
4.1.7. Implantable Infusion Pumps
4.1.8. Others
4.2. North America Volumetric Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
4.2.1. Chemotherapy
4.2.2. Diabetes
4.2.3. Gastroenterology
4.2.4. Analgesia/Pain Management
4.2.5. Pediatrics/Neonatology
4.2.6. Hematology
4.2.7. Others
4.3. North America Volumetric Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.3.1. U.S. Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
4.3.2. U.S. Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
4.3.3. Canada Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
4.3.4. Canada Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
4.4. BPS Analysis/Market Attractiveness Analysis
5. Europe Volumetric Infusion Pumps Market Outlook, 2020-2033
5.1. Europe Volumetric Infusion Pumps Market Outlook, by Product Outlook, Value (US$ Bn), 2020-2033
5.1.1. Volumetric Infusion Pumps
5.1.2. Insulin Infusion Pumps
5.1.3. Syringe Infusion Pumps
5.1.4. Enteral Infusion Pumps
5.1.5. Ambulatory Infusion Pumps
5.1.6. Patient Controlled Analgesia (PCA)
5.1.7. Implantable Infusion Pumps
5.1.8. Others
5.2. Europe Volumetric Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
5.2.1. Chemotherapy
5.2.2. Diabetes
5.2.3. Gastroenterology
5.2.4. Analgesia/Pain Management
5.2.5. Pediatrics/Neonatology
5.2.6. Hematology
5.2.7. Others
5.3. Europe Volumetric Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.3.1. Germany Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
5.3.2. Germany Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
5.3.3. Italy Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
5.3.4. Italy Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
5.3.5. France Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
5.3.6. France Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
5.3.7. U.K. Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
5.3.8. U.K. Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
5.3.9. Spain Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
5.3.10. Spain Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
5.3.11. Russia Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
5.3.12. Russia Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
5.3.13. Rest of Europe Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
5.3.14. Rest of Europe Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
5.4. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Volumetric Infusion Pumps Market Outlook, 2020-2033
6.1. Asia Pacific Volumetric Infusion Pumps Market Outlook, by Product Outlook, Value (US$ Bn), 2020-2033
6.1.1. Volumetric Infusion Pumps
6.1.2. Insulin Infusion Pumps
6.1.3. Syringe Infusion Pumps
6.1.4. Enteral Infusion Pumps
6.1.5. Ambulatory Infusion Pumps
6.1.6. Patient Controlled Analgesia (PCA)
6.1.7. Implantable Infusion Pumps
6.1.8. Others
6.2. Asia Pacific Volumetric Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
6.2.1. Chemotherapy
6.2.2. Diabetes
6.2.3. Gastroenterology
6.2.4. Analgesia/Pain Management
6.2.5. Pediatrics/Neonatology
6.2.6. Hematology
6.2.7. Others
6.3. Asia Pacific Volumetric Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.3.1. China Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
6.3.2. China Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
6.3.3. Japan Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
6.3.4. Japan Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
6.3.5. South Korea Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
6.3.6. South Korea Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
6.3.7. India Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
6.3.8. India Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
6.3.9. Southeast Asia Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
6.3.10. Southeast Asia Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
6.3.11. Rest of SAO Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
6.3.12. Rest of SAO Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
6.4. BPS Analysis/Market Attractiveness Analysis
7. Latin America Volumetric Infusion Pumps Market Outlook, 2020-2033
7.1. Latin America Volumetric Infusion Pumps Market Outlook, by Product Outlook, Value (US$ Bn), 2020-2033
7.1.1. Volumetric Infusion Pumps
7.1.2. Insulin Infusion Pumps
7.1.3. Syringe Infusion Pumps
7.1.4. Enteral Infusion Pumps
7.1.5. Ambulatory Infusion Pumps
7.1.6. Patient Controlled Analgesia (PCA)
7.1.7. Implantable Infusion Pumps
7.1.8. Others
7.2. Latin America Volumetric Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
7.2.1. Chemotherapy
7.2.2. Diabetes
7.2.3. Gastroenterology
7.2.4. Analgesia/Pain Management
7.2.5. Pediatrics/Neonatology
7.2.6. Hematology
7.2.7. Others
7.3. Latin America Volumetric Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.3.1. Brazil Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
7.3.2. Brazil Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
7.3.3. Mexico Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
7.3.4. Mexico Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
7.3.5. Argentina Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
7.3.6. Argentina Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
7.3.7. Rest of LATAM Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
7.3.8. Rest of LATAM Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
7.4. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Volumetric Infusion Pumps Market Outlook, 2020-2033
8.1. Middle East & Africa Volumetric Infusion Pumps Market Outlook, by Product Outlook, Value (US$ Bn), 2020-2033
8.1.1. Volumetric Infusion Pumps
8.1.2. Insulin Infusion Pumps
8.1.3. Syringe Infusion Pumps
8.1.4. Enteral Infusion Pumps
8.1.5. Ambulatory Infusion Pumps
8.1.6. Patient Controlled Analgesia (PCA)
8.1.7. Implantable Infusion Pumps
8.1.8. Others
8.2. Middle East & Africa Volumetric Infusion Pumps Market Outlook, by Disease Indication, Value (US$ Bn), 2020-2033
8.2.1. Chemotherapy
8.2.2. Diabetes
8.2.3. Gastroenterology
8.2.4. Analgesia/Pain Management
8.2.5. Pediatrics/Neonatology
8.2.6. Hematology
8.2.7. Others
8.3. Middle East & Africa Volumetric Infusion Pumps Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.3.1. GCC Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
8.3.2. GCC Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
8.3.3. South Africa Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
8.3.4. South Africa Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
8.3.5. Egypt Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
8.3.6. Egypt Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
8.3.7. Nigeria Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
8.3.8. Nigeria Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
8.3.9. Rest of Middle East Volumetric Infusion Pumps Market Outlook, by Product Outlook, 2020-2033
8.3.10. Rest of Middle East Volumetric Infusion Pumps Market Outlook, by Disease Indication, 2020-2033
8.4. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. 3M
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Braun Melsungen AG
9.4.3. Baxter
9.4.4. Becton Dickinson and Company
9.4.5. Fresenius Kabi AG
9.4.6. ICU Medical Inc
9.4.7. Smiths Medical
9.4.8. Terumo Medical Corporation
9.4.9. Avanos Medical, Inc.
9.4.10. Medtronic plc
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations